Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PHILADELPHIA, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Shareholder law firm Kaskela Law LLC announces that it is investigating Discover Financial Services (NYSE: DFS) (“Discover Financial”) on behalf of...
-
PHILADELPHIA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating EngageSmart, Inc. (NYSE: ESMT) (“EngageSmart”) on behalf of the company’s shareholders. On...
-
PHILADELPHIA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Consolidated Communications Holdings, Inc. (NASDAQ: CNSL) (“Consolidated Communications”) on behalf...
-
PHILADELPHIA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) on behalf of investors in...
-
PHILADELPHIA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Sonos, Inc. (NASDAQ: SONO) (“Sonos”) on behalf of the company’s investors. Since May 2023, shares...
-
PHILADELPHIA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating T2 Biosystems, Inc. (NASDAQ: TTOO) (“T2”) on behalf of the company’s investors. Since October...
-
PHILADELPHIA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Bloom Energy Corp. (NYSE: BE) (“Bloom”) on behalf of the company’s investors. Since January 2023,...
-
PHILADELPHIA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Frontier Group Holdings, Inc. (NASDAQ: ULCC) (“Frontier”) on behalf of the company’s investors. ...
-
PHILADELPHIA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Nurix Therapeutics, Inc. (NASDAQ: NRIX) (“Nurix”) on behalf of the company’s investors. Since...
-
PHILADELPHIA, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Prelude Therapeutics Inc. (NASDAQ: PRLD) (“Prelude”) on behalf of the company’s investors. Since...